Brouillard Adam M, Sun Xingwen, Siddiqui Adnan H, Lin Ning
Department of Neurosurgery, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York.
Department of Neurosurgery, Weill Cornell Medical College ; New York Presbyterian Hospital.
Cureus. 2016 Jan 28;8(1):e472. doi: 10.7759/cureus.472.
Flow diversion is a novel concept for treating anatomically challenging intracranial aneurysms and has gained increasing acceptance. Flow diverter stents, such as the Pipeline Embolization Device (PED) (ev3-Covidien, Irvine, CA, USA), are approved for treating unruptured large and giant aneurysms from the internal carotid artery between the superior hypophyseal and cavernous segments. However, technological advances and recent clinical results suggest that flow diversion can be safely and effectively used in treating ruptured aneurysms, posterior circulation aneurysms, and distal anterior circulation aneurysms. In this brief review, we aim to investigate the recent evidence on the utilization of PEDs in these controversial vascular territories and to discuss whether the indications for flow diversion can be expanded.
血流导向是治疗解剖结构复杂的颅内动脉瘤的一种新理念,且越来越被人们所接受。血流导向支架,如Pipeline栓塞装置(PED)(美国加利福尼亚州欧文市ev3-柯惠公司),已被批准用于治疗垂体上动脉段和海绵窦段之间颈内动脉的未破裂大型和巨大动脉瘤。然而,技术进步和近期临床结果表明,血流导向可安全有效地用于治疗破裂动脉瘤、后循环动脉瘤和前循环远端动脉瘤。在这篇简短的综述中,我们旨在研究PEDs在这些有争议的血管区域应用的最新证据,并讨论血流导向的适应证是否可以扩大。